Insulinlike growth factor 1 and insulinlike growth factor 3: Indices of intestinal failure in children

Journal of Pediatric Surgery

Volumn 34, Issue 5, 1999, Pages 655-662

  Barksdale Jr , Edward M ^a   Koehler, Anita N ^b   Yaworski, Jane Anne ^b   Gardner, Mary ^b   Reyes, Jorge ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

Growth hormone; Insulinlike growth factor binding protein 3; Insulinlike growth factor 1; Intestinal adaptation; Short bowel syndrome

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ADULT; ANTHROPOMETRY; BODY HEIGHT; BODY WEIGHT; BONE AGE; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GROWTH DISORDER; HUMAN; INFANT; MALE; PRIORITY JOURNAL; SEROLOGY; SHORT BOWEL SYNDROME; THYROID FUNCTION;

EID: 13044279479     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(99)90350-0     Document Type: Conference Paper

References (25)

1. Wilmore DW: Factors correlating with a successful outcome following extensive intestinal resection in newborn infants. J Pediatr 80:88-95, 1972
2. Cooper A, Floyd TF, Ross AJ, et al: Morbidity and mortality of short bowel syndrome acquired in infancy: An update. J Pediatr Surg 19:711-718, 1984
3. Weber TR, Tracy T Jr, Connors RH: Short bowel syndrome in children. Arch Surg 126:841-846, 1991
4. Kurkchubasche AG, Rowe MI, Smith SD: Adaptation in short bowel syndrome: Reassessing old limits. J Pediatr Surg 28:1060-1071, 1993
5. Caniano DA, Starr J, Ginn PM: Extensive short bowel syndrome in neonates: Outcome in the 1980's. Surgery 105:119-204, 1989
6. Williamson RC: Intestinal adaptation (Part 1): Structural, functional & cytokinetic changes. N Engl J Med 298:1393-1402, 1978
7. Schwartz MZ, Kosaka M: Short bowel syndrome in infants and children. Pediatr Clin North Am 32:1265-1279, 1985
8. Vanderhoof JA, Langnas AN, Lewis WP, et al: Invited review: Short bowel syndrome. J Pediatr Gastroenterol Nutr 14:359-370, 1992
9. Williamson RC: Intestinal adaptation (Part II): Mechanisms of control. N Engl J Med 298:1444-1450, 1978
10. Wilmore DW, Byrne TA, Persinger RL: Short bowel syndrome: New therapeutic approaches. Curr Probl Surg 34:391-444, 1997
11. Dudrick SJ, Latifi R, Fosnocht DE: Management of short bowel syndrome. Surg Clin North Am 71:625-643, 1991
12. Byrne TA, Persinger RL, Young LS, et al: A new treatment for patients with short bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 3:243-255, 1995
13. Warner BW, Ziegler MM: Management of the short bowel syndrome in the pediatric population. Pediatr Clin North Am 40:1335-1350, 1993
14. Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, CA, Stanford University Press, 1993
15. Hamill PVV, Drizd TA, Johnson CL, et al: Physical growth: National center for health statistics percentiles. Am J Clin Nutr 32:607-629, 1979
16. Conover CA: Regulation and physiological role of insulin-like growth factor binding proteins. Endocr J 43:S43-S48, 1996
17. LeRoith D: Insulin-like growth factors. N Engl J Med 336:633-640, 1997
18. Haymond MW: The rationale for the use of recombinant human growth hormone and insulin-like growth Factor 1 for catabolic conditions in humans. Horm Res 46:202-207, 1996
19. Rabkin R: Nutrient regulation of insulin-like growth factor 1. Miner Electrolyte Metab 23:157-160, 1997
20. Ranke MB, Elmlinger M: Functional role of insulin-like growth factor binding proteins. Horm Res 48:9-15, 1997
21. Ohneda K, Ulshen MH, Fuller C: Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth Factor 1. Gastroenterology 112:444-454, 1976
22. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34, 1998
23. Castilla-Cortazar I, Nunez M, Urdaneta E, et al: Low dose of insulin-like growth factor (IGF-1) restore intestinal galactose transport and microvilli structure in cirrhotic rats. J Hepatol 25:64, 1996 (suppl)
24. Ohneda K, Ulshen MH, Fuller CR, et al: Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor 1. Gastroenterology 112:444-454, 1997
25. Haymond MW, Mauras N: The rationale for the use of recombinant human growth hormone and insulin-like factor 1 for catabolic conditions in humans. Horm Res 46:202-207, 1996